🚨 Beware of Fake Job Offers from Scammers Impersonating AcuraStem 🚨 We have been made aware of recent scams where individuals are receiving fake job offers that falsely claim to be from AcuraStem.Please be cautious as these offers may appear legitimate. It’s important to note: AcuraStem does not reach out directly via email or social media to solicit personal information or make job offers. All legitimate AcuraStem job opportunities are posted on our official website and through verified job boards. If you receive any suspicious communication, do not reply or click on any links. Verify all job offers by visiting our official career opportunities page (https://lnkd.in/eKUe5Ktc).
关于我们
AcuraStem (acurastem.com) is a patient-based, drug development company pioneering drug discovery and ultimately how treatments are developed for neurodegenerative diseases—including sporadic ALS and FTD. Enabled by our ground-breaking iNeuroRx® technology platform - AcuraStem has discovered and is now advancing drug candidates that promise to strongly impact disease progression for most patients, including those for whom the genetic cause of their disease is unknown (i.e. sporadic ALS and FTD patients). The causes of neurodegenerative diseases are complex, and genetically defined forms of disease (e.g. C9ORF72-ALS and FTD) only account for a small percentage of cases. Thus, many scientists didn’t believe it was possible to develop a single effective treatment that could work broadly for all patients. But AcuraStem has shown with its extremely promising therapeutic programs for ALS and FTD that it can be done. Go to acurastem.com to find out more
- 网站
-
http://www.acurastem.com
AcuraStem的外部链接
- 所属行业
- 生物技术研究
- 规模
- 11-50 人
- 总部
- Pasadena，CA
- 类型
- 私人持股
- 创立
- 2016
地点
-
主要
获取路线
150 North Orange Grove Blvd.
Suite 220
US，CA，Pasadena，91103
AcuraStem员工
动态
-
California ALS Summit Recap: At the 15th annual ALS Network Research Summit in San Francisco, AcuraStem Associate Vice President, Discovery and Early Development, Wen-Hsuan (Wen) Chang, presented “Development of an UNC13A ASO for ALS” AcuraStem was proud to once again sponsor the ALS Network Research Summit. Learn more about the event and AcuraStem’s iNeuroRX® technology platform—the gold standard for discovering novel, effective, and broadly-acting treatments—along with our patient-based approach to combating neurodegenerative diseases. Go to 👉 https://pxl.to/hmplpm #ALSSummit #AcuraStem #NeurodegenerativeResearch #iNeuroRX #ALSResearch #UNC13A #CaliforniaScience #BiotechInnovation #PatientDriven #ScienceForGood
-
AcuraStem is delivering high-impact ALS therapeutics. Join us at the Neuroscience Innovation Pharma Partnering Summit in Boston (Feb 18-19), where CSO Marcel van der Brug will showcase the groundbreaking advancements made possible by our iNeuroRx® platform in the discovery of disease-modifying therapies for ALS and FTD. We’ve already partnered with Takeda on our PIKFYVE program—now we’re advancing UNC13A and SYF2 antisense oligonucleotide drug candidates. AcuraStem’s best-in-class ALS models power the discovery of translatable therapies that modify key disease phenotypes, including survival. 📍 Presentation: “Using the iNeuroRx® Platform to Develop Disease-Modifying Treatments for ALS & FTD” Are you committed to ending ALS? Let’s connect in Boston and explore partnership opportunities. acurastem.com #AcuraStem #EndALS #FTDAwareness #NeuroscienceInnovation #PharmaPartnering #iNeuroRx #DiseaseModifyingTherapies #ALSResearch #BiotechInnovation #JoinUsInBoston
-
AcuraStem转发了
✨Meet our Executive Advisor Wen-Hsuan (Wen) Chang from AcuraStem✨ Interested in joining Women In Bio? You can learn more about WIB membership and gain access to our video library, mentorship opportunities, and more here: https://lnkd.in/eSDv3Tsd #LifeSciencesLA #BiotechLA #HealthTechLA #WomenInSTEM #Networking #WomenInLifeSciences #WomenInBiotech #WomenInPharma #WomenInResearch #WomenInBio #WomenInBioLosAngeles #WIB #WIBLA
-
-
🚨Today in San Francisco: AcuraStem Associate Vice President, Discovery and Early Development Wen-Hsuan (Wen) Chang will be presenting on “Development of an UNC13A ASO for ALS” at the 15th annual ALS Network Research Summit on January 17 in San Francisco. AcuraStem is proud to once again sponsor the ALS Network Research Summit. Wen, along with AcuraStem CEO Sam Alworth, and CSO Marcel van der Brug will be on-site and available to discuss AcuraStem's latest advancements. Don’t miss this opportunity to meet with them and learn more about our cutting-edge iNeuroRX® technology platform—the gold standard for discovering novel, effective, and broadly-acting treatments, and our patient-based approach to combating neurodegenerative disease. Learn more about AcuraStem and our work in neurodegenerative disease research at 👉 acurastem.com #endALS #ALS #cureALStogether #ourALScommunity #alsawareness
-
🚨Friday: AcuraStem Associate Vice President, Discovery and Early Development Wen-Hsuan (Wen) Chang will be presenting on “Development of an UNC13A ASO for ALS” at the 15th annual ALS Network Research Summit on January 17 in San Francisco. AcuraStem is proud to once again sponsor the ALS Network Research Summit. Wen, along with AcuraStem CEO Sam Alworth, and CSO Marcel van der Brug will be on-site and available to discuss AcuraStem's latest advancements. Don’t miss this opportunity to meet with them and learn more about our cutting-edge iNeuroRX® technology platform—the gold standard for discovering novel, effective, and broadly-acting treatments, and our patient-based approach to combating neurodegenerative disease. Learn more about AcuraStem and our work in neurodegenerative disease research at 👉 acurastem.com #endALS #ALS, #cureALStogether #ourALScommunity #alsawareness
-
We're #hiring a new Associate Vice President Translational Sciences in Pasadena, California. Apply today or share this post with your network.
-
Starting today! Connect with AcuraStem's executive team at JPM 2025...
🤝 Connect with AcuraStem’s executive team. CEO Sam Alworth, Associate Vice President of Discovery and Early Development Wen-Hsuan (Wen) Chang, and Chief Scientific Officer Marcel van der Brug will be attending the 43rd Annual JP Morgan Healthcare Conference, January 13-16, 2025, in San Francisco, CA. This premier event is the largest and most informative healthcare investment symposium in the industry, connecting global industry leaders, emerging fast-growth companies, innovative technology creators, and members of the investment community. Sam, Wen, and Marcel will be on-site and available to discuss AcuraStem's latest advancements. Don’t miss this opportunity to meet them and learn more about our cutting-edge iNeuroRX® technology platform—the gold standard for discovering novel, effective, and broadly-acting treatments, and our patient-based approach to combating neurodegenerative diseases. Discover more about AcuraStem’s commitment to advancing the development of treatments for neurodegenerative diseases by visiting acurastem.com.
-
🚨Just Announced: AcuraStem Associate Vice President, Discovery and Early Development Wen-Hsuan (Wen) Chang will be presenting on “Development of an UNC13A ASO for ALS” at the 15th annual ALS Network Research Summit on January 17 in San Francisco. AcuraStem is proud to once again sponsor the ALS Network Research Summit. Wen, along with AcuraStem CEO Sam Alworth, and CSO Marcel van der Brug will be on-site and available to discuss AcuraStem's latest advancements. Don’t miss this opportunity to meet with them and learn more about our cutting-edge iNeuroRX® technology platform—the gold standard for discovering novel, effective, and broadly-acting treatments, and our patient-based approach to combating neurodegenerative disease. Learn more about AcuraStem and our work in neurodegenerative disease research at 👉 acurastem.com
-
AcuraStem转发了
🎉 Exciting News from EverythingALS! 🎉 We are thrilled to welcome AcuraStem to the EverythingALS research network! AcuraStem is a patient-based biotechnology company leading the way in developing groundbreaking treatments for neurodegenerative diseases, including sporadic ALS and FTD. With their proprietary platform, iNeuroRx®, AcuraStem sets the gold standard in discovering effective, novel and broadly-acting therapies. This partnership reflects our shared commitment to advancing research, accelerating innovation and ultimately improving the lives of those living with ALS. Stay tuned for more updates as we collaborate to bring hope and progress to the ALS community! #ALS #NeurodegenerativeDiseases #Research #Innovation
-